Preterm birth is the leading factor causing neonatal mortality and morbidity. Inflammation plays a central role in stimulating uterine contractility, which is responsible for approximately one-third of all preterm births. Recent studies have shown that the transcription factor Forkhead box O3 (FOXO3) regulates inflammation in nongestational tissues such as adipocytes and hepatocytes. Thus, in this study, we sought to determine the effect of 1) human term labor on myometrial FOXO3 expression and 2) FOXO3 inhibition and FOXO3 overexpression on proinflammatory and prolabor mediators in human myometrial cells. Higher FOXO3 gene and protein expression were detected in myometrium obtained from women in labor when compared to samples taken from nonlaboring women. Myometrial cells were isolated from pregnant human myometrium, and FOXO3 silencing was achieved using siRNA and overexpression using a cDNA clone. We found that the loss of FOXO3 in myometrial cells was associated with a significant decrease in IL1B-induced IL6 and IL8 expression and production, cyclooxygenase ([COX]-2, official symbol PTGS2) expression and subsequent prostaglandin (PGE 2 and PGF 2alpha ) release, and matrix metalloproteinase 9 (MMP9) and mRNA expression and activity. Conversely, FOXO3 overexpression increased cytokine expression and secretion, prostaglandin production, and MMP9 expression in myometrial cells treated with IL1B. In summary, we have identified FOXO3 as an upstream mediator of inflammation in human myometrium. Thus, FOXO3 may present an alternative therapeutic target for preventing preterm birth and its associated morbidity and mortality.
INTRODUCTION
Preterm birth is a major global health issue. It is the major contributor to deaths in children under one year of age [1, 2] . Survivors of preterm birth have greatly increased risks of lifelong health disabilities, both mental and physical, including cerebral palsy and chronic lung disease [2] . Preterm birth is associated with an enormous burden on the economy [3] as well as a considerable emotional burden for the families. Although important insights into the pathophysiology of preterm labor have been gleaned over the past several decades and despite avid attempts, there are currently no effective treatments that can prevent premature uterine activation. Research directed at understanding the mechanisms of uterine quiescence and contractility will significantly impact the development of efficacious therapeutics in the management of preterm labor.
It is well established that preterm labor is associated with an increase in proinflammatory signaling molecules in the intrauterine environment [4, 5] . Leukocytes can traffic into the myometrium and can release proinflammatory cytokines to amplify or initiate the process of parturition. This leads to the activation of nuclear factor-KB (NFKB)-driven gene transcription, including proinflammatory cytokines (IL1B, IL6, TNF), chemokines (e.g., IL8), PTGS2, prostaglandins, and extracellular matrix (ECM) remodeling enzymes (e.g., matrix metalloproteinase 9 (MMP9), which initiate spontaneous premature uterine contractions [5] [6] [7] [8] [9] [10] [11] [12] .
Several recent studies have proposed a role for Forkhead box class O3 (FOXO3), a member of the FOXO transcription factor subfamily, in the regulation of inflammation in vitro and in vivo [13, 14] . Depending on the cell type and pathological conditions, FOXO3 exhibits very different roles in the regulation of inflammation. For example, overexpression of FOXO3 in T cells inhibited NFKB activation and cytokine expression [15] ; conversely, inactivation of FOXO3 by bacterial infection or TNF contributes to increased cytokine expression in intestinal epithelial cells [16, 17] . Further, mice deficient in FOXO3 develop spontaneous, multisystemic inflammatory syndrome, which is associated with increased cytokine production and increased NFKB activation [15] ; however, this was not apparent in other FOXO3-mutant strains [18] [19] [20] . On the other hand, in human umbilical vein, endothelial cells serum starvation or heat shock induces endogenous FOXO3 activation, leading to the upregulation of MMP3 and apoptosis [21] ; FOXO3 induces MMP9 and MMP13 expression and activity in cancer cells [22] ; in macrophages, HIV infection activates FOXO3, which contributes to the apoptosis of infected cells [23] ; and in human lung, epithelial adenocarcinoma A549 cells, coexpression of constitutively active FOXO3 increased iNOS promoter activity and mRNA levels, thus contributing to inflammation [24] . Additionally, in human embryonic kidney 293T cells, colon cancer HCT116 cells, and cervical cancer HeLa cells, overexpression of FOXO3 increased and knockdown of FOXO3 repressed NFKB activities [25] .
We have previously described the presence of FOXO3 in human placenta and fetal membranes [26] . Of note, we found that FOXO3 expression was increased in fetal membranes overlying the cervix, suggesting a role in the mechanisms of membrane rupture. As described above, FOXO3 has been causally linked to multiple cellular processes that are activated during human parturition [19, [27] [28] [29] [30] [31] [32] ; however, whether FOXO3 regulates proinflammatory cytokines and prolabor mediators in human pregnant myometrium has yet to be determined. Thus, in this study, the effect of FOXO3 knockdown and overexpression on proinflammatory mediators, induced by IL1B, in primary human myometrial cells was investigated. In addition, the effect of human labor on FOXO3 expression was also determined.
MATERIALS AND METHODS

Sample Collection
Human myometrium was obtained (with the Research Ethics Committee of Mercy Health approval) from consenting women at the time of term Cesarean section (!37 wk gestation). Myometrial biopsies were collected from two groups of women: 1) pregnant women undergoing elective Cesarean section in the absence of labor (n ¼ 6 patients) and 2) pregnant women who were delivered during active labor (labor was defined as the presence of regular uterine contractions [every 3-4 min] resulting in cervical effacement and dilation) (n ¼ 6 patients). Women were excluded from the study if they had a multiple pregnancy and evidence of active infection. A myometrial biopsy was obtained from the upper margin of the lower uterine segment incision during the Cesarean section. The samples were snap frozen in liquid nitrogen and stored at À808C.
Immunohistochemistry
To determine the localization of FOXO3 in human myometrium, immunohistochemistry was performed as described previously [33, 34] . Rabbit polyclonal anti-FOXO3 (sc-11351) from Santa Cruz Biotechnology (Santa Cruz, CA) was used at 1 lg/ml. Negative control slides, where primary antibody was replaced with normal rabbit IgG serum, were also included.
Myometrial Cell Culture
For these studies, biopsies of term human myometrium were collected at the time of Cesarean section from women not in labor. Myometrial tissue was washed in PBS and finely dissected. Myometrium was minced and digested for 45 min in Dulbecco Modified Eagle Medium/Nutrient F-12 Ham (DMEM/F-12) with 3 mg/ml type 1 collagenase (Worthington Biochemical, Freehold, NJ) and 80 lg/ml DNase I (Roche Diagnostics, Castle Hill, NSW, Australia). Cells were centrifuged at 400 3 g for 10 min and grown in a 75-cm 2 flask in DMEM/ F-12 with 10% heat-inactivated fetal calf serum (FCS), 2 mM L-glutamine, 100 U/ml penicillin, and 100 lg/ml streptomycin (378C and 5% CO 2 -21% O 2 ). Myometrial cells from passage 1-4 were trypsinized in TrypLE Express (Life Technologies, Grand Island, NY) and cultured in 12-well plates in DMEM/F-12 with 10% heat-inactivated FCS, 2 mM L-glutamine, 100 U/ml penicillin, and 100 lg/ml streptomycin until they reached the required confluence. The purity of the cell population was confirmed by assessing smooth muscle actin using immunohistochemistry. All samples of myometrium were strongly positive for smooth muscle actin.
In order to determine the effect of IL1B on FOXO3 expression, myometrial cells at approximately 90% confluency were incubated in with or without 1 ng/ ml IL1B for 3, 6, and 20 h. At the end of each incubation, cells were collected and stored at À808C until assayed for FOXO3 protein expression by Western blotting as detailed below. Experiments were performed on myometrium from three patients.
Silencing of FOXO3 with siRNA in Primary Myometrial Cells
Cells at approximately 50% confluency were transfected using SilenceMag reagent according to manufacturer guidelines (Oz Biosciences, Marseille, France). Transfections were performed as we have previously described [35] [36] [37] . Cells were transfected with 100 nM FOXO3 or nonspecific (NS) siRNA (Ambion, Austin, TX) in DMEM/F-12 for 72 h. The medium was then replaced with DMEM/F-12 (containing 0.5% BSA), with or without 1 ng/ml IL1B, and the cells incubated at 378C for an additional 24 h. Cells were collected and stored at À808C until assayed for mRNA expression by qRT-PCR and protein expression by Western blotting as detailed below. Media were collected and stored at À808C until assayed for cytokine and prostaglandin release as detailed below. The response to IL1B between patients varied greatly. Thus, data are presented as fold change in expression relative to the expression level in the IL1B-stimulated NS siRNA transfected cells, which was set at 1. Experiments were performed on myometrium from seven patients.
Overexpression of FOXO3 in Primary Myometrial Cells
A transfection-ready FOXO3 human cDNA clone, vector pCMV6-XL4 (Origene, Rockville, MD) was used; an empty pCMV6 vector was used as the control plasmid. Primary myometrial cells were prepared as described above. Cells at approximately 80% confluence were transfected using ExtremeGENE 9 DNA Transfection Reagent (Roche Diagnostics) according to manufacturer guidelines. Cells were transfected with 1 lg FOXO3 plasmid or control plasmid for 48 h. The medium was then replaced with DMEM/F-12 (containing 0.5% BSA), with or without 1 ng/ml IL1B, and the cells incubated at 378C for an additional 24 h. In order to determine whether NFKB is required for FOXO3 to exert its effects, some experiments were also performed in the presence of the NFKB inhibitor BAY 11-7082 (10 lM). Cells were collected and stored at À808C until assayed for mRNA expression by qRT-PCR and protein expression by Western blotting as detailed below. Media were collected and stored at À808C until assayed for cytokine, prostaglandin, and MMP release as detailed below. The response to IL1B between patients varied greatly. Thus, data are presented as fold change in expression relative to the expression level in the IL1B-stimulated empty vector transfected cells, which was set at 1. Experiments were performed on myometrium from seven patients.
Luciferase Assay
A luciferase assay was utilized to determine possible interactions between FOXO3 and NFKB. Primary myometrial cells, prepared as described above, at approximately 70% confluence were transfected using X-tremeGene HP DNA Transfection Reagent according to manufacturer guidelines. Cells were transfected with 0.25 lg pNFKB-luc (Qiagen, Germantown, MD) plus either 0.5 lg empty pcMV6-XL5 plasmid or 0.5 lg FOXO3 plasmid for 48 h. The medium was then replaced with DMEM/F-12 with 2% heat-inactivated FCS, with or without 1 ng/ml IL1B, and the cells incubated at 378C for an additional 24 h. The cells were harvested in lysis buffer, and luminescence activity was measured using the Dual-Glo Luciferase Assay kit (Promega, Madison, WI) as instructed. The results are expressed as a ratio of luciferase activity of IL1B-stimulated NFKB reporter plus empty pCMV6 vector group, which was set at 1. Experiments were performed from myometrium obtained from six patients.
A luciferase assay was also performed to determine if BAY 11-7082 decreases NFKB transcriptional activity. To do this, myometrial cells (n ¼ 3 patients) were transfected with 0.25 lg pNFKB-luc 48 h as detailed above. The cells were then treated with 1 ng/ml IL1B in the absence or presence of the NFKB inhibitor BAY 11-7082 (10 lM) for an additional 24 h. Luminescence activity was measured as detailed above.
RNA Extraction and Quantitative RT-PCR
RNA extractions and quantitative RT-PCR (qRT-PCR) were performed as we have previously described [37] . Briefly, total RNA was extracted using TriReagent according to manufacturer instructions (Sigma-Aldrich, St. Louis, MO). RNA concentration and purity were measured using a NanoDrop ND1000 spectrophotometer (Thermo Scientific, Pittsburgh, PA). RNA was converted to cDNA using the SuperScript VILO cDNA synthesis kit (Invitrogen, Carlsbad, CA) according to the manufacturer's instructions. The cDNA was diluted 50-fold, and 4 ll of cDNA were used to perform RT-PCR using Sensimix Plus SYBR green (Quantace, Alexandria, NSW, Australia) and 100 nM of QuantiTect Primer Assays (Qiagen). Average gene C T values were normalized to the average GAPDH C T values of the same cDNA sample. RNA without reverse transcriptase during cDNA synthesis as well as PCR reactions using water instead of template showed no amplification. Fold differences were determined using the comparative C T method.
Western Blotting
Total protein was extracted with RIPA lysis buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1% Igepal, 0.1% SDS, 0.25% Na deoxycholate, 1 mM EDTA, pH 7.4). The supernatant was separated from cell debris by centrifugation at 15 000 3 g for 15 min at 48C. Protein concentrations were determined by Protein Assay (Pierce, Rockford, IL) and BSA reference LIM ET AL.
standards. Samples were stored at À808C, and electrophoresis was carried out as previously described [38] . Blots were incubated with 1 lg/ml rabbit polyclonal anti-FOXO3 (sc-11351) from Santa Cruz Biotechnology diluted in blocking buffer (5% skim milk/TBS-T [0.05%]) for 16 h at 48C. For protein loading control in Figure 1B , blots were stained with 0.1% Ponceau-S in 5% acetic acid, rinsed in distilled water to clear background, and then imaged using Quantity One software [39] . For all other figures, mouse monoclonal b-actin (A5316; Sigma) was used as a loading control. Membranes were viewed and analyzed using the Chemi-Doc system (Bio-Rad Laboratories, Hercules, CA). Quantitative analysis of the relative density of the bands in Western blots was performed using Quantity One 4.2.1 image analysis software (Bio-Rad). After normalization against the loading control, data are expressed as the ratio of the average of the controls.
Cytokine and Prostaglandin Immunoassays
The release of IL6 and IL8 was performed by sandwich ELISA according to the manufacturer's instructions (Invitrogen). The release of PGE 2 and PGF 2a into the incubation medium was assayed using commercially available competitive enzyme immunoassay kits (Kookaburra Kits from Sapphire Bioscience, Redfern, NSW, Australia). The protein content of tissue homogenates was determined using BCA protein assay (Pierce), using BSA as a reference standard, as previously described [38, 40, 41] .
Gelatin Zymography
Conditioned medium was collected and assessment of MMP9 was performed by gelatin zymography as previously described [42] . Proteolytic activity was visualized as clear zones of lysis on a blue background of undigested gelatin. Quantitative analysis of the relative density was performed using Quantity One 4.2.1 image analysis software (Bio-Rad). Data were corrected for background, and fold change was calculated relative to IL1B-stimulated cells.
Statistical Analysis
Statistical analysis was performed using a commercially available statistical software package (Statgraphics Plus version 3.1, Statistical Graphics Corp., Rockville, MD). For Figure 1 , FOXO3 expression is relative to the average of FOXO3 expression in the nonlaboring group, and two sample comparisons were analyzed by a paired sample comparison. For Figure 2 , FOXO3 is expressed relative to 3-h basal expression, and two sample comparisons were analyzed by a Student t-test. For Figures 3-7 , data are presented as fold change in expression relative to the expression level in the IL1B-stimulated cells, which was set at 1. For these data, analysis was performed using a one-way analysis of variance (ANOVA; using least-significant-difference correction to discriminate among the means). Statistical significance was ascribed to a Pvalue ,0.05. All data are expressed as mean 6 SEM.
RESULTS
Effect of Human Labor on FOXO3 Expression in Human Myometrium
The first aim of this study was to determine the effect of human labor on FOXO3 gene and protein expression in human myometrium. We examined FOXO3 expression in myometrium from women at term Cesarean section in the absence of labor (no labor; n ¼ 6 patients) and after spontaneous labor onset (in labor; n ¼ 6 patients). FOXO3 mRNA (Fig. 1A) and protein (Fig. 1B) expression in myometrium obtained from women in labor was significantly higher compared to that expressed in myometrium from women prior to the onset of labor. Immunohistochemistry was used to determine the localization of FOXO3 in human pregnant myometrium at term (Fig. 1C) . Within sections of myometrium, strong cytoplasmic FOXO3 protein was localized to myometrial smooth muscle cells (myocytes). No staining was observed in the negative control.
The Proinflammatory Cytokine IL1B Increases FOXO3 Expression in Primary Human Myometrial Cells
The proinflammatory cytokine IL1B is increased with term and preterm labor and is thought to play an important role in regulating myometrial contractions. Thus, we next sought to determine the effect of IL1B on FOXO3 expression. To do this, FIG. 1. Effect of human labor on FOXO3 expression in human myometrium. Human myometrium was obtained from nonlaboring and laboring women (n ¼ 6 per group). A) FOXO3 expression was analyzed by qRT-PCR and normalized to GAPDH mRNA expression and fold change expressed relative to the average of the nonlaboring group. Data is displayed as mean 6 SEM. *P , 0.05 versus no labor (Student t-test) . B) Western blot and quantitation for FOXO3. Expression levels were confirmed by densitometry. Representative Western blot from eight patients (four nonlaboring patients and four in-labor patients) is shown. FOXO3 protein expression was normalized to the loading control, and fold change expressed relative to the average of the nonlaboring group. Data are displayed as the mean 6 SEM. *P , 0.05 versus no labor (Student t-test). C) Immunolocalization of FOXO3 in myometrium from pregnant women at term not in labor. A negative control is also displayed. Original magnification 3100.
FOXO3 REGULATES PROLABOR MEDIATORS IN MYOMETRIUM
myometrial cells were incubated with or without 1 ng/ml IL1B for 3, 6, and 20 h, and FOXO3 protein expression was assessed by Western blotting. A representative Western blot image and quantitation for FOXO3 is shown in Figure 2 . After 3 h of incubation with IL1B, there was an increase in FOXO3 expression. However, there was no effect of 6 or 20 h of IL1B treatment on FOXO3 expression.
Efficacy of FOXO3 Transfection in Primary Human Myometrial Cells
After having established that FOXO3 expression is elevated in the myometrium during labor and by the proinflammatory cytokine IL1B, we sought to identify the downstream targets of FOXO3 signaling in the myometrium. In this study, we used both loss of function and gain of function studies to determine if FOXO3 regulates proinflammatory and prolabor mediators in human myometrium. To do this, we extracted myocytes from human pregnant myometrium and knocked out FOXO3 using siRNA or overexpressed FOXO3 using a plasmid. The efficacy of transfection was analyzed by qRT-PCR and Western blotting, and the data are presented in Figure 3 . Compared to NS siRNA transfected cells, transfection with FOXO3 siRNA resulted in a significant decrease in FOXO3 mRNA (Fig. 3A) and protein expression (Fig. 3B) . In contrast, compared to cells transfected with an empty pCMV6 vector, transfection with the FOXO3 plasmid resulted in a significant increase in FOXO3 at the level of the gene (Fig. 3C) and protein (Fig. 3D) .
FOXO3 Regulates the Expression and Release of Proinflammatory Cytokines in Primary Human Myometrial Cells
For all subsequent loss of function studies, human pregnant myometrial cells were transfected with either 100 nM NS
-of-function studies, human pregnant myometrial cells were transfected with 1 lg of empty pCMV6 vector or FOXO3 plasmid for 48 h, followed by incubation with 1 ng/ ml of IL1B for 24 h.
The effect of FOXO3 inhibition and FOXO3 overexpression on IL1B-induced proinflammatory cytokine gene expression and release from primary uterine myocytes is demonstrated in Figure 4 . As expected, in myometrial cells transfected with NS siRNA (Fig. 4, A and B) or empty vector (Fig. 4, C and D) , IL1B treatment significantly increased IL6 and IL8 gene expression (Fig. 4A) and release (Fig. 4B) . In myometrial cells where FOXO3 was knocked down, this increase was significantly blunted (Fig. 4, A and B) . Conversely, in myometrial cells where FOXO3 was overexpressed, IL6 and IL8 cytokine gene expression and production was significantly augmented (Fig. 4, C and D) .
FOXO3 Regulates PTGS2 Expression and Resultant Prostaglandin Release in Primary Human Myometrial Cells
IL1B induced an increase in PTGS2 mRNA expression, and PGE 2 and PGF 2a release (Fig. 5) . In cells deficient in FOXO3, this increase in PTGS2 mRNA expression (Fig. 5A) , and PGE 2 and PGF 2a release (Fig. 5B ) was significantly attenuated. On the other hand, overexpression of FOXO3 statistically augmented PTGS2 mRNA expression (Fig. 5C ) and the release of PGE 2 and PGF 2a (Fig. 5D ).
FOXO3 Regulates Expression and Release of ECMDegrading Enzyme MMP9 in Primary Human Myometrial Cells
MMP9 mRNA expression and activity in response to FOXO3 inhibition and overexpression is depicted in Figure 6 . The qRT-PCR analysis was used to detect MMP9 transcripts (Fig. 6 , A and C), and gelatin zymography was used to detect the enzymatic activity of secreted MMP9 (Fig. 6, B and D) . In NS siRNA transfected cells or in cells transfected with the empty plasmid, IL1B activated both the transcription of MMP9 and the enzymatic activity of active MMP9. The response to IL1B was blunted in FOXO3-deficient cells and significantly augmented in FOXO3-overexpressing cells.
FOXO3 Does Not Activate NFKB Transcriptional Activity
Our findings above show that FOXO3 stimulates prolabor mediators in inflammation-inflicted myometrial cells. FOXO3 may promote overproduction of prolabor mediators in an independent manner. Alternatively, FOXO3 may mediate these effects through interacting with other transcription factors. Indeed, studies in nongestational tissues report that FOXO3 is a positive regulator of NFKB [25] , a well-characterized pathway that is responsible for inducing prolabor mediators in human gestational tissues under inflammatory conditions [34, 43, 44] .
To determine whether the NFKB might be a direct target of FOXO3, we transfected primary myometrial cells with an NFKB-luc reporter in the absence (control vector pcDNA3.1 vector) or presence of FOXO3 expression vector for 48 h. Cells were then stimulated with 1 ng/ml IL1B for an additional 24 h, and NFKB transcriptional activity was assessed by luminescence. As shown in Figure 7 , in myometrial cells expressing the NFKB-luc reporter, treatment with IL1B significantly increased luciferase activity. There was, however, no effect of 
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FOXO3 overexpression on IL1B-induced NFKB-mediated luciferase reporter expression.
FOXO3 Does Not Exert Its Prolabor Effects via NFKB
The final aim was to determine whether NFKB is required for the FOXO3 effects described above. Firstly, using a luciferase assay, we confirmed that BAY 11-7082 significantly decreased IL1B-induced luciferase activity in myometrial cells expressing the NFKB-luc (data not shown). We then overexpressed FOXO3 in myometrial cells using an expression vector for 48 h. Cells were then stimulated with 1 ng/ml IL1B in the absence or presence of 10 lM BAY 11-7082 for an additional 24 h. There was no effect of BAY 11-7082 on proinflammatory cytokines, prostaglandins and MMP-9 (data not shown).
DISCUSSION
In this article, we report that the gene and protein expression of the transcription factor FOXO3 is significantly increased in term myometrium at labor compared with nonlaboring tissues. In addition, we show the early induction of FOXO3 expression in response to the proinflammatory cytokine IL1B. Similarly, other studies have reported increases in FOXO3 expression in a number of inflammatory diseases. FOXO3 is activated during bacterial infection in respiratory epithelial cells and in human bronchial epithelium of patients with infection-related lung diseases [45] . Increased FOXO3 expression has been also detected in whole blood polymorphonuclear cells from rheumatoid arthritis patients [46] , in inflammatory infiltrates of the sublining area of rheumatoid arthritis synovium [46] , in the brains of patients with Parkinson's disease [47] , and in malignant pleural mesothelioma, a highly aggressive neoplasm [48] .
There is an association between human labor and the inflammatory process as evidenced by the influx of inflammatory cells into the myometrium and cervix and increased production of proinflammatory cytokines within these tissues [6, 49, 50] . However, it should be noted that there is conflicting evidence about inflammatory cell infiltration into cervical and myometrial tissues in during normal labor. Keski-Nisula et al. [51] showed very little leukocyte infiltration in laboring myometrium and only small increases in decidual infiltration with labor. Nevertheless, increased expression of FOXO3 in myometrium during labor is suggestive of a role in this process. Thus, in this study, we investigated the effect of FOXO3 inhibition and overexpression on the expression and secretion of prolabor mediators in human uterine smooth muscle cells in response to IL1B. The loss of FOXO3 was associated with a decrease in IL1B-induced expression of proinflammatory cytokines IL6 and IL8, PTGS2 expression and resultant prostaglandin release, and expression and activity of MMP9. Conversely, overexpression of FOXO3 was associated with increased IL6 and IL8 expression and release, PTGS2 expression and subsequent prostaglandin production, and MMP9 expression and activity.
The role of cytokines during human parturition is vast; they modulate processes such as cervical ripening and myometrial contractions by promoting synthesis of nitric oxide, prostaglandins, and MMPs and regulating PTGS2-dependent prostaglandin production [49, 52, 53] . Increased IL6 concentrations in amniotic fluid and maternal serum is indicative of intraamniotic infection, failed tocolysis, and preterm birth [54, 55] . It is thought that IL6 may play an indirect role in labor by upregulating gene expression of oxytocin receptors on myometrial cells, increasing their responsiveness to oxytocin stimulation and thus initiating contractions [56] . Additionally, the chemokine IL8 is thought to promote cervical remodeling, with distinct softening and dilation seen in cervices treated with IL8 [57] , and myometrial contractility, as an influx of leukocytes in the myometrium [58] and cervix, is associated with parturition [50] . The present study demonstrates that while IL1B increases cytokine gene expression and production in human pregnant myometrium, inhibition of FOXO3 negates this effect; conversely, overexpression of FOXO3 increases IL1B-induced cytokine expression. Our results indicate that FOXO3 plays a proinflammatory role in human myometrium.
The PTGS2-prostaglandin pathway plays an important role in regulating myometrial contractility [53] . PTGS2 is induced in tissues following exposure to bacteria as well as inflammatory cytokines; IL1B up-regulates PTGS2 synthesis, which in turn drives prostaglandin production, which then acts further in processes such as myometrial contractility [50] . The oxytocic effect of prostaglandin was first reported in 1968 [59] ; labor was induced in 10 women by intravenous administration of PGF 2a . Indomethacin is an anti-inflammatory drug and the only tocolytic that has proven to delay delivery past 37 wk. Indomethacin inhibited spontaneous contractions of myometrial strips by inhibiting calcium channel currents [60] . However, as with other tocolytics, there are side effects for both mother and baby to be considered. The present study demonstrates that inhibition of FOXO3 decreased IL1B-induced PTGS2 gene expression and PGE 2 production; however, further study is required to determine whether FOXO3 inhibitors would be efficient tocolytics.
FOXO3 inhibition in human pregnant myometrial cells decreased MMP9 expression and activity, with the reverse seen in cells overexpressing FOXO3. MMPs play an important role in human parturition, including uterine tissue remodeling during labor [49] . Concomitant with our study, reports have shown that depletion of FOXO3 from cancer cells lead to decreased tumor size due to decreased invasive migration as seen by decreased MMP9 expression [22] . Nuclear retention of FOXO3 also greatly increased MMP9 and MMP13 expression and thus invasive migration. FOXO3 also induces MMP3 and suppresses tissue inhibitor of metalloproteinase 1 (TIMP1) expression in endothelial cells [21] . Enzymatic activity of MMP9 was increased after FOXO3 activation but not protein or mRNA expression [21] . Furthermore, serum starvation or heat shock also induces activation of endogenous FOXO3, leading to activation of MMP3 and apoptosis [21] .
Oxidative stress and apoptosis have also been linked to the processes of human labor in the myometrium [61] [62] [63] [64] . The high oxygen requirement for the energy necessary for muscle contractions in the progression of human labor can lead to imbalances between oxidant and antioxidant levels; this imbalance has been noted in preterm infants with insufficiently developed antioxidant defense systems [65, 66] . The molecular mechanisms involved in the switch from uterine quiescence to contractile activity, while largely unknown, coincide with activation of the intrinsic apoptotic pathway [53] . Activation of the caspase cascade may regulate the transition from myometrial proliferative to contractile phase [67] , and, prior to labor, changes in the myometrial fibers reflect apoptosis [68] . Myometrial apoptosis is associated with inflammation and preterm delivery [69, 70] . In nongestational tissues, FOXO3 has been shown to regulate both oxidative stress and apoptosis. For example, overexpression of active FOXO3 in insulin-resistant macrophages undergoing endoplasmic reticulum stress exacerbated apoptosis, with the converse seen in macrophages deficient in FOXO3 showing a decreased apoptotic response [71] . In endometrial decidualized cells, LIM ET AL. 
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expression of a constitutively active FOXO3 triggers apoptosis, whereas silencing of endogenous FOXO3 expression in undifferentiated decidual cells abrogates apoptosis induced by free radicals [72] . In line with these studies, we have also previously described FOXO3 expression and localization in human gestational tissues and reported that FOXO3 expression was higher in fetal membranes overlying the cervix compared to those obtained from a more distal site [26] . Of note, these fetal membranes are known to have increased oxidative stress [73] and apoptosis [74, 75] , which contributes to the rupture of membranes. Collectively, these studies support the results presented in this paper and suggest that FOXO3 plays a proinflammatory role in human labor.
Our findings above show that FOXO3 stimulates prolabor mediators in inflammation-inflicted myometrial cells. FOXO3 functions as a transcription factor through its direct DNA binding and interaction with other transcription factors, including NFKB. NFKB is a proinflammatory transcription factor that plays a key role in the physiology and pathophysiology of human labor [34, 43, 44] . Labor and delivery are associated with changes in NFKB content and/or activity in fetal membranes, cervix, and myometrium. Inhibition of NFKB activity in ex situ human gestational tissues suppresses the formation of labor-mediating effectors, including proinflammatory cytokines, PTGS2-prostaglandin pathways, and ECM remodeling enzymes. Myometrial IL8 expression is increased by stretch and IL1B in an NFKB-dependent manner [28, 76] . Consistent with these observations, chromatin immune precipitation analysis has revealed that NFKB binds to the IL8 promoter on IL1B stimulation [76] . There is now emerging data to suggest that FOXO3 mediates many of its actions via interaction with NFKB [15, 25] . A very recently published study has found that overexpression of FOXO3 increased and knockdown of FOXO3 repressed NFKB transcriptional activity [25] . This led us to the hypothesis that FOXO3 may also mediate its effects in human myometrium by altering the activity of NFKB. In this study, using luciferase assays, we show that there was no effect of FOXO3 overexpression on NFKB transcriptional activity, suggesting that FOXO3 is not upstream of NFKB in this system. In addition, we found that in cells overexpressing FOXO, there was no effect of pharmacological inhibition of the NFKB signaling pathway on prolabor mediators. This suggests 6 patients) . A, C) MMP9 gene expression was normalized to GAPDH mRNA expression, and the fold change was calculated relative to IL1B-stimulated NS siRNA/empty vector transfected cells. Data are displayed as mean 6 SEM (one-way ANOVA). *P , 0.05 versus IL1B-stimulated NS siRNA/ empty vector transfected cells. B, D) The incubation medium was assayed for MMP9 activity by gelatin zymography. Zymography from one patient is shown. Active MMP9 levels were confirmed by densitometry, and the fold change was calculated relative to IL1B-stimulated NS siRNA transfected cells. Each bar represents the mean 6 SEM (one-way ANOVA; n ¼ 4 patients). *P , 0.05 versus IL1B-stimulated NS siRNA transfected cells.
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Article 156 that NFKB activity is not required for the proinflammatory effects of FOXO3 in myometrium. The actions of FOXO3 may be due to interaction with cofactor or corepressor proteins. For example, FOXO proteins interact with cofactor proteins; acetylation of FOXO3 by CBP/ p300 promotes histone acetylation, thus attenuating FOXOmediated transcription of target genes [77] . Further studies are required to elucidate whether such interactions also mediate the effects of FOXO3 in human pregnant myometrium.
FOXO3 has an important role in the regulation of inflammation in vitro and in vivo. Depending on the cell type and pathological conditions, FOXO3 exhibits very different roles in the regulation of inflammation. Here, we report that FOXO3 has proinflammatory actions, where overexpression increases inflammation and silencing of FOXO3 decreases inflammation. However, there are also reports of FOXO3 having anti-inflammatory actions. For example, mice deficient in FOXO3 developed spontaneous, multisystemic inflammatory syndrome, which was associated with increased cytokine production [15] . Loss of FOXO3 leads to severe intestinal inflammation [17] , augments lung inflammation in response to cigarette smoke in mice [78, 79] , and contributes to increased cytokine expression in intestinal HT-29 cells [16, 17] .
Preterm labor is often a prelude to early births and the significant attendant burden of infant morbidity and mortality. The etiology of preterm labor is multifactorial; however, there are a number of important pathways that lead to preterm birth, including infection and/or inflammation [80] . Thus, understanding the role of inflammation in initiating uterine contractions is required in order to develop therapeutic strategies for the treatment and prevention of preterm labor. In this study, we present a novel role for FOXO3 in the terminal processes of human labor and delivery. We have shown that FOXO3 is increased in myometrium from laboring pregnant women and in the presence of the proinflammatory cytokine IL1B. In addition, we report that FOXO3 has proinflammatory and prolabor effects in human pregnant myometrium; silencing of FOXO3 decreased IL1B-induced cytokine expression, prostaglandin production, and MMP9 activity, and overexpression of FOXO3 was associated with an increase in cytokines, prostaglandins, and MMP9 activity. Further research is required to determine whether FOXO3 inhibitors could be used as a therapeutic for threatened preterm labor, with minimal side effects to both mother and baby.
